Compare IGC & FOFO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | IGC | FOFO |
|---|---|---|
| Founded | 2005 | 2017 |
| Country | United States | Hong Kong |
| Employees | N/A | 14 |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 28.9M | 29.7M |
| IPO Year | 2005 | N/A |
| Metric | IGC | FOFO |
|---|---|---|
| Price | $0.29 | $2.04 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $5.25 | N/A |
| AVG Volume (30 Days) | ★ 466.5K | 53.2K |
| Earning Date | 03-19-2026 | 03-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 59.09 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $1,271,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $13.06 | N/A |
| P/E Ratio | ★ N/A | $11.09 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.24 | $1.82 |
| 52 Week High | $0.50 | $68.00 |
| Indicator | IGC | FOFO |
|---|---|---|
| Relative Strength Index (RSI) | 43.80 | 33.03 |
| Support Level | $0.28 | N/A |
| Resistance Level | $0.31 | $5.74 |
| Average True Range (ATR) | 0.01 | 0.25 |
| MACD | -0.00 | 0.02 |
| Stochastic Oscillator | 29.01 | 31.25 |
IGC Pharma Inc develops cannabinoid-based formulations for treating diseases and conditions, including, but not limited to, Alzheimer's disease, period cramps, premenstrual syndrome, and chronic pain. The company has investigational drug assets targeting Alzheimer's disease, IGC-AD1, IGC-M3, IGC-1C, and TGR-63, which have demonstrated in Alzheimer's cell lines the potential to be effective in suppressing or ameliorating key hallmarks of Alzheimer's disease, such as plaques or tangles.
Hang Feng Technology Innovation Co Ltd is committed to providing comprehensive corporate management consulting and asset management services, tailored to address the specific needs of each client. Its goal is to empower its clients to design, implement, and achieve their unique business and investment objectives. Its business consists of two main segments: (i) corporate management consulting services and (ii) asset management services. The corporate management consulting services include Management consulting, and Regulatory compliance and governance consulting.